GPX4 and chronic kidney disease: WB and RT-qPCR assays of GPX4 generated results consistent with those of IF (Fig. 2c–e), whereas the expression trend of ACSL4 was opposite to that of GPX4, with lowest expression in the Sham group and highest in the CKD + CDDP group (Fig. 2d, f).